Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Portable Artificial Heart Driver Helps Patients Stay Mobile

By HospiMedica International staff writers
Posted on 07 Apr 2010
A portable artificial heart driver could soon offer "bridge to transplant” patients the option of being discharged from the hospital while awaiting an appropriate donor heart. More...


The Freedom driver system is a portable driver designed to power the SynCardia (Tucson, AZ, USA) CardioWest Total Artificial Heart, for use at their home, in their communities, and at step-down facilities. The Freedom driver weighs six kilograms, including two onboard lithium ion batteries and a power adaptor. It can be conveniently carried by the patient in a proprietary backpack or shoulder bag. The Freedom driver uses a "dark cockpit" design, meaning the driver only flashes a light and sounds an alarm when something requires the user's attention. No onsite repair or inventory of parts is required by the hospital, and service for the driver will only be by replacement via express delivery.

The Freedom driver system has received the European Community (CE marking) approval, and has concomitantly received conditional approval from the U.S. Food & Drug Administration (FDA) to conduct an investigational device exemption (IDE) clinical study of the system. The trial is expected to enroll 60 patients and will follow them until transplant, 90 days after discharge, or death.

"The new Freedom driver is the first wearable portable driver for powering the Total Artificial Heart,” said Rodger Ford, president and CEO of SynCardia. "It will allow stable European Total Artificial Heart patients to enjoy a quality lifestyle at home and in their communities while they wait for a matching donor heart.”

"While waiting for a transplant, patients can stay in the hospital for several months and in some rare cases, more than a year,” said Stephen Clayson, M.D., of the Utah Artificial Heart Program at Intermountain Medical Center (Murray, UT, USA). "We are pleased to initiate the IDE clinical study and evaluate the use of the Freedom driver to power the Total Artificial Heart. If the IDE clinical study of the Freedom driver is successful, patients will be able to sleep in their own bed, spend time with their families, and be more self-sufficient.”

Related Links:
SynCardia
Intermountain Medical Center


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Pressure Guidewire
SavvyWire
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.